World's Best Scientists 2026 revealed!
Jennifer F Hoy

Jennifer F Hoy

D-Index & Metrics

Immunology

D-Index
62
Citations
25901
World Ranking
3087
National Ranking
130

Overview

Jennifer F Hoy is affiliated with Monash University in Australia and has a research focus predominantly within the field of Medicine, particularly in Infectious Diseases. Their scholarly output includes work across several subfields such as Emergency Medicine, Epidemiology, Virology, and Surgery.

The primary topics of Jennifer F Hoy's research revolve around HIV/AIDS, including HIV/AIDS research and interventions, HIV-related health complications and treatments, drug development and treatment for HIV/AIDS, and investigations into HIV, drug use, and sexual risk. Additional research interests cover Pneumocystis jirovecii pneumonia detection and treatment, as well as social issues related to sex work.

Jennifer F Hoy's recent notable publications include:

  • Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults, 2022, JAMA
  • Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults, 2020, JAMA
  • Antiretroviral Drugs for Treatment and Prevention of HIV in Adults: 2024 Recommendations of the International Antiviral Society-USA Panel, 2024, JAMA
  • HIV is associated with an increased risk of age-related clonal hematopoiesis among older adults, 2021, Nature Medicine
  • Incidence of dyslipidemia in people with HIV who are treated with integrase inhibitors versus other antiretroviral agents, 2021, AIDS

The venues where Jennifer F Hoy frequently publishes include:

  • AIDS
  • The Lancet HIV
  • JAMA
  • HIV Medicine
  • UNC Libraries

Collaborative research is an aspect of Jennifer F Hoy's work, with frequent co-authors including James McMahon, Christopher K. Fairley, Huldrych F. Günthard, David J. Templeton, and Kathy Petoumenos. These collaborations reflect a network of researchers engaged in the study and treatment of HIV and related health concerns.

Best Publications

  • Circulating microRNAs in sera correlate with soluble biomarkers of immune activation but do not predict mortality in ART treated individuals with HIV-1 infection : a case control study

    Daniel D. Murray;Kazuo Suzuki;Matthew Law;Jonel Trebicka

  • CD4+ count-guided interruption of antiretroviral treatment.

    Wafaa El-Sadr;Wafaa El-Sadr;Jens D Lundgren;James Neaton;Fred Gordin

  • Antiretroviral Treatment of Adult HIV Infection: 2012 Recommendations of the International Antiviral Society–USA Panel

    Huldrych F Gunthard;Judith A Aberg;Joseph J Eron;Jennifer Frances Hoy

  • Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2016 Recommendations of the International Antiviral Society–USA Panel

    Huldrych F. Günthard;Michael S. Saag;Constance A. Benson;Carlos del Rio

  • Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2018 Recommendations of the International Antiviral Society–USA Panel

    Michael S. Saag;Constance A. Benson;Rajesh T. Gandhi;Jennifer F. Hoy

  • Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2022 Recommendations of the International Antiviral Society-USA Panel.

    Unknown

  • Activation of HIV transcription with short-course vorinostat in HIV-infected patients on suppressive antiretroviral therapy.

    Julian H. Elliott;Fiona Wightman;Ajantha Solomon;Khader Ghneim

  • Viral suppression and HIV transmission in serodiscordant male couples: an international, prospective, observational, cohort study

    Benjamin R Bavinton;Angie N Pinto;Nittaya Phanuphak;Beatriz Grinsztejn

  • Predictive value of CD4 lymphocyte numbers for the development of opportunistic infections and malignancies in HIV-infected persons.

    S M Crowe;J B Carlin;K I Stewart;C R Lucas

  • Antiretroviral treatment of adult HIV infection: 2014 recommendations of the International Antiviral Society-USA Panel.

    Unknown

  • Antiretroviral Drugs for Treatment and Prevention of HIV Infection in Adults: 2020 Recommendations of the International Antiviral Society-USA Panel.

    Michael S. Saag;Rajesh T. Gandhi;Jennifer F. Hoy;Raphael J. Landovitz

  • Association of HIV Preexposure Prophylaxis With Incidence of Sexually Transmitted Infections Among Individuals at High Risk of HIV Infection.

    Michael W. Traeger;Vincent J. Cornelisse;Jason Asselin;Brian Price

  • Abacavir substitution for nucleoside analogs in patients with HIV lipoatrophy: a randomized trial.

    Andrew Carr;Cassy Workman;Don E. Smith;Jennifer Hoy

  • Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study.

    Allison Martin;Don E Smith;Andrew Carr;Clare Ringland

  • New spectrum of fungal infections in patients with cancer.

    Elias Anaissie;Gerald P. Bodey;Hagop M Kantarjian;Jae Ro

  • Liposomal amphotericin B (AmBisome) compared with amphotericin B both followed by oral fluconazole in the treatment of Aids-associated cryptococcal meningitis

    A.C.A.P. Leenders;P. Reiss;P. Portegies;K. Clezy

  • Continuous antiretroviral therapy decreases bone mineral density.

    Birgit Grund;Grace Peng;Cynthia L. Gibert;Jennifer F. Hoy

  • Quadruple-Drug Therapy for Mycobacterium avium-intracellulare Bacteremia in AIDS Patients

    Jennifer Hoy;Anne Mijch;Murray Sandland;Lindsay Grayson

  • Cardiovascular risk factors associated with lower baseline cognitive performance in HIV-positive persons.

    Edwina Wright;Edwina Wright;Edwina Wright;B Grund;K Robertson;Bruce Brew;Bruce Brew

  • HIV protease inhibitor substitution in patients with lipodystrophy: a randomized, controlled, open-label, multicentre study.

    Andrew M Carr;Jeff Hudson;John Chuah;Simon Mallal

  • Trichosporon beigelii infection: a review.

    Jennifer Hoy;Kuo Ching Hsu;Kenneth V Rolston;Roy L. Hopfer

  • Recommendations for Evaluation and Management of Bone Disease in HIV

    Todd T. Brown;Jennifer Hoy;Marco Borderi;Giovanni Guaraldi

  • HIV Infection and High Density Lipoprotein Metabolism

    Honor May Rose;Jennifer F Hoy;Jennifer F Hoy;Ian John Woolley;Ian John Woolley;Urbain Tchoua

Frequent Co-Authors

David A. Cooper
David A. Cooper University of New South Wales
Sharon R. Lewin
Sharon R. Lewin University of Melbourne
Andrew Carr
Andrew Carr University of Oxford
Suzanne M. Crowe
Suzanne M. Crowe Burnet Institute
Christopher K. Fairley
Christopher K. Fairley Monash University
Matthew Law
Matthew Law University of New South Wales
Sean Emery
Sean Emery University of New South Wales
Margaret Hellard
Margaret Hellard Burnet Institute
Mark Stoove
Mark Stoove Burnet Institute
Allen C. Cheng
Allen C. Cheng Monash University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in advancing their immunology knowledge and healthcare careers, exploring related nursing degrees and certifications can open new doors. Transitioning from a Family Nurse Practitioner (FNP) to specialize in more critical care roles is a strategic option, with options like acute care NP certification providing the necessary credentials.

Many students seek flexibility and speed in their education, which is why accelerated NP programs online have become popular. These programs offer an efficient path to becoming a nurse practitioner, aligning well with busy professionals’ schedules.

For individuals without a nursing background, pursuing an online degree can be less intimidating with online BSN programs for non nurses. These programs tailor the curriculum to support learners new to nursing while preparing them for clinical excellence.

Additionally, those seeking the quickest entry into nursing might consider options like the easiest ABSN program to get into. These accelerated programs focus on accessibility and fast-tracked training to meet the demand for qualified nurses swiftly.

Best Scientists Citing Jennifer F Hoy

Trending Scientists